LEGN
Legend Biotech Corporation · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +30.0% ·
aandelenstroom -10.0% ·
netto nieuwe posities +20.0%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 91 | +11 | 61.76M | $1.78B | +16 | −5 |
| Q1 2026 | 82 | -3 | 51.41M | $929.52M | +5 | −8 |
| Q4 2025 | 86 | +2 | 50.21M | $1.09B | +2 | — |
| Q3 2025 | 13 | -2 | 38.53M | $1.26B | — | −2 |
| Q2 2025 | 12 | -1 | 34.51M | $1.22B | +1 | −2 |
| Q1 2025 | 10 | 0 | 13.38M | $453.85M | — | — |
| Q4 2024 | 10 | -1 | 15.80M | $514.13M | — | −1 |
| Q3 2024 | 10 | +3 | 16.52M | $804.74M | +3 | — |
| Q2 2024 | 7 | — | 18.35M | $812.58M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 11.17M | -2.8% | $544.10M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 11.17M | -2.8% | $544.10M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.04M | -27.5% | $99.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.04M | -27.5% | $99.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.04M | -27.5% | $99.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.04M | -27.5% | $99.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.04M | -27.5% | $99.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.04M | -27.5% | $99.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.04M | -27.5% | $99.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.32M | -8.9% | $64.16M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 1.32M | -8.9% | $64.16M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 12 | Millennium Management ✦ | 570.38K | -65.6% | $27.79M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Marshall Wace ✦ | 494.37K | Nieuw | $24.09M | 0.0% | New | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 494.37K | Nieuw | $24.09M | 0.0% | New | 1 | SEC ↗ |
| 15 | Geode Capital Management ✦ (passief) | 494.86K | +3.6% | $23.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passief) | 494.86K | +3.6% | $23.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 195.37K | -35.8% | $9.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 165.97K | +0.3% | $8.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 60.50K | Nieuw | $2.95M | 0.0% | New | 1 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 18.10K | Nieuw | $882,013 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Marshall Wace | $24.09M | 0.0% |
| Marshall Wace | $24.09M | 0.0% |
| Two Sigma Investments | $2.95M | 0.0% |
| Renaissance Technologies | $882,013 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 189 houders, 95.78M aandelen, $1.69B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.